Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression

Experimental Hematology

Volumn 31, Issue 3, 2003, Pages 197-203

  Skarpidi, Evangelia ^a   Cao, Hua ^a   Heltweg, Birgit ^b   White, Brian F ^c   Marhenke, Ronald L ^d   Jung, Manfred ^b   Stamatoyannopoulos, George ^a,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TE Neesby Inc   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; BUTYRIC ACID; BUTYRYLHYDROXAMIC ACID; CHEMICAL COMPOUND; GLOBIN; HEMOGLOBIN F; HISTONE DEACETYLASE; LUCIFERASE; MESSENGER RNA; PROPIONIC HYDROXAMIC ACID; PROPIONOHYDROXAMIC ACID; SHORT CHAIN FATTY ACID; SUBEROHYDROXAMIC ACID; UNCLASSIFIED DRUG; VORINOSTAT;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BIOASSAY; CELL CULTURE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME SUBSTRATE; ERYTHROBLAST; EXPERIMENTAL TEST; FETUS; GENE EXPRESSION; GLOBIN GENE; IC 50; IN VITRO STUDY; INHIBITION (PSYCHOLOGY); LIVER; MEASUREMENT; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; SCREENING;

RENILLA;

EID: 0037335407     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)01030-5     Document Type: Article

References (46)

1. Stamatoyannopoulos G., Grosveld F. Hemoglobin switching. Stamatoyannopoulos G., Majerus P.W., Perlmutter R.M.et al. The Molecular Basis of Blood Diseases. 2001;135 W.B. Saunders, Philadelphia.
2. Perrine S.P., Rudolph A., Faller D.V.et al. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 85:1988;8540.
3. Perrine S.P., Miller B.A., Faller D.V.et al. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood. 74:1989;454.
4. Constantoulakis P., Knitter G., Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates. in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC Blood. 74:1989;1963.
5. Liakopoulou E., Blau C.A., Li Q.et al. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 86:1995;3227.
6. Torkelson S., White B., Faller D.V., Phipps K., Pantazis C., Perrine S.P. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells Mol Dis. 22:1996;150.
7. Skarpidi E., Vassilopoulos G., Li Q., Stamatoyannopoulos G. Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood. 96:2000;321.
8. Richon V.M., Emiliani S., Verdin E.et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A. 95:1998;3003.
9. Richon V.M., Sandhoff T.W., Rifkind R.A., Marks P.A. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A. 97:2000;10014.
10. Jones L.W., Wallis E.S. The Beckman rearrangement involving optionally active radicals. J Am Chem Soc. 48:1926;169.
11. Stowell J.C., Huot R.I., Van Voast L. The synthesis of N-hydroxy-N-phenyl-octanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells. J Med Chem. 38:1995;1411.
12. Hoffmann K., Brosch G., Loidl P., Jung M. A non-isotopic assay for histone deacetylase activity. Nucleic Acids Res. 27:1999;2057.
13. Hoffmann K., Brosch G., Loidl P., Jung M. First non-radioactive assay for in vitro screening of histone deacetylase inhibitors. Pharmazie. 55:2000;601.
14. Heltweg B., Jung M. A micro plate reader based non-isotopic histone deacetylase activity assay. Anal Biochem. 302:2002;175.
15. Heltweg B., Jung M. Eosin Y as an internal standard for a plate reader based quantitation of a histone deacetylase substrate. Arch Pharm Pharm Med Chem. 335:2002;296.
16. Constantoulakis P., Nakamoto B., Papayannopoulou T., Stamatoyannopoulos G. Fetal calf serum contains activities that induce fetal hemoglobin in adult erythroid cell cultures. Blood. 75:1990;1862.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
18. Li Q., Stamatoyannopoulos J.A. Position independence and proper developmental control of gamma-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol Cell Biol. 14:1994;6087.
19. Thorpe S.J., Thein S.L., Sampietro M., Craig J.E., Mahon B., Huehns E.R. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis. Br J Haematol. 87:1994;125.
20. Stamatoyannopoulos J.A., Nienhuis A.W. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies. Annu Rev Med. 43:1992;497.
21. Papayannopoulou T.H., Brice M., Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis in bone marrow cultures from adult individuals. Proc Natl Acad Sci U S A. 73:1992;2033.
22. DeSimone J., Biel S.I., Heller P. Stimulation of fetal hemoglobin synthesis in baboons by hemolysis and hypoxia. Proc Natl Acad Sci U S A. 75:1978;2937.
23. Papayannopoulou T., Vichinsky E., Stamatoyannopoulos G. Fetal Hb production during acute erythroid expansion. I. Observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol. 44:1980;535.
24. DeSimone J., Heller P., Hall L., Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci U S A. 79:1982;4428.
25. Papayannopoulou T., Torrealba de Ron A., Veith R., Knitter G., Stamatoyannopoulos G. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science. 224:1984;617.
26. Letvin N.L., Linch D.C., Beardsley G.P., McIntyre K.W., Nathan D.G. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 310:1984;869.
27. Veith R., Papayannopoulou T., Kurachi S., Stamatoyannopoulos G. Treatment of baboon with vinblastine. insights into the mechanisms of pharmacologic stimulation of HbF in the adult Blood. 66:1985;456.
28. Veith R., Dautenhahn A.G., Roth R.C. Methotrexate stimulates fetal hemoglobin production in anemic baboons. Prog Clin Biol Res. 316:1989;363.
29. Platt O.S., Orkin S.H., Dover G., Beardsley G.P., Miller B., Nathan D.G. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 74:1984;652.
30. Veith R., Galanello R., Papayannopoulou T., Stamatoyannopoulos G. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N Engl J Med. 313:1985;1571.
31. Charache S., Terrin M.L., Moore R.D.et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 332:1995;1317.
32. Loukopoulos D., Voskaridou E., Kalotychou V., Schina M., Loutradi A., Theodoropoulos I. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea. the experience of a single center in Greece Blood Cells Mol Dis. 26:2000;453.
33. Al-Khatti A., Veith R.W., Papayannopoulou T., Fritsch E.F., Goldwasser E., Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Engl J Med. 317:1987;415.
34. Nagel R.L., Vichinsky E., Shah M.et al. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin. a double-blind study Blood. 81:1993;9.
35. Constantoulakis P., Papayannopoulou T., Stamatoyannopoulos G. alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood. 72:1988;1961.
36. Perrine S.P., Ginder G.D., Faller D.V.et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 328:1988;81.
37. Sher G.D., Ginder G.D., Little J., Yang S., Dover G.J., Olivieri N.F. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. N Engl J Med. 332:1995;1606.
38. Atweh G.F., Sutton M., Nassif I.et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 93:1999;1790.
39. Perrine S.P., Dover G.H., Daftari P.et al. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. Br J Haematol. 88:1994;555.
40. Dover G.J., Brusilow S., Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 84:1994;339.
41. Collins A.F., Pearson H.A., Giardina P., McDonagh K.T., Brusilow S.W., Dover G.J. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia. a clinical trial Blood. 85:1995;43.
42. Cappellini M., Graziadei G., Ciceri L.et al. Oral isobutyramide therapy in patients with thalassemia intermedia. results of a phase II open study Blood Cells Mol Dis. 26:2000;105.
43. Reich S., Buhrer C., Henz G.et al. Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia. Blood. 96:2000;3357.
44. Stamatoyannopoulos G., Blau C.A., Nakamoto B.et al. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood. 84:1994;3198.
45. Finnin M.S., Donigian J.R., Cohen A.et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 401:1999;188.
46. Marks P.A., Richon V.M., Rifkind R.A. Histone deacetylase inhibitors. inducers of differentiation or apoptosis of transformed cells J Natl Cancer Inst. 92:2000;1210.